Cookies and the protection of your data

We use cookies to improve the functionality of the website, to offer you a better website experience and to provide social media features. You give your consent by clicking on “Accept all Cookies” or as part of your individual settings. Please find detailed information on the use of cookies on this website in our Data Privacy Statement.

Functional Cookies

These cookies are necessary for the operation of the site and enable security-relevant functions. In addition, we determine whether you want to remain logged in and to make our services available to you when you change between this and other websites.

Statistical Cookies

These cookies are used for analyzing user behavior on our website with the aim of improving user navigation. All data collected is evaluated anonymously. Further information is available on our data protection site.

Marketing Cookies

These cookies are used to deliver relevant advertising or to limit how many times you see an ad. Marketing cookies can share that information with the advertiser (third-party cookies). The legal basis for the data processing is the consent of the user.

Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
Haema Series
2025

Share:

Haema Series

Automated Blood Coagulation Analyzer

Medcaptain Medical Technology Co., Ltd.

The Haema series is a fully automatic coagulation analyzer designed for secondary hospitals and large laboratory departments.The product can add consumables and samples without stopping, realizing the automatic loading and unloading and discarding of sample reagents, and also supporting the automatic re-dissolution and reservation quality control functions, improving the overall test efficiency and greatly simplifying the testing workload. In addition, the color contrast of the injection port highlights the main interaction area. The appearance is inspired by the spacecraft shape, highlighting the sense of the future.

Date of Launch
2024
Development Time
up to 24 Month
Target Regions
Africa, Asia, Australia / Oceania, Europe, North America
Target Groups
Public Sector / Government, "nosocomium"

RELATED PROJECTS